NCT07221643

Brief Summary

This study aims to examine the connection between the level of carotenoids in the skin and a number of immune related health parameters.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 30, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

October 9, 2025

Completed
19 days until next milestone

First Posted

Study publicly available on registry

October 28, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

December 15, 2025

Status Verified

October 1, 2025

Enrollment Period

5 months

First QC Date

September 30, 2025

Last Update Submit

December 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Skin carotenoid levels and skin aging features

    We will assess the skin carotenoid levels' correlation with skin aging features, such as wrinkles, fine lines, and age spots.

    one day

Secondary Outcomes (2)

  • Skin carotenoid levels and biomarkers of aging

    one day

  • Skin carotenoid levels and self-reported perception of health

    2 weeks

Study Arms (2)

Young adult

Participants are 18 to 30 years old.

Older adult

Participants are over 65 years old.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Healthy individuals who are either between 18 to 30 years old or over 65 years old.

You may qualify if:

  • Willing and able to provide written informed consent
  • Age 18-30 years OR 65 years and older
  • Healthy individuals without uncontrolled medical conditions (over the counter inhaled and topical steroids allowed)
  • Fiitzpatrick I-VI (all skin types)

You may not qualify if:

  • Pregnant or breastfeeding
  • uncontrolled medical conditions
  • Skin conditions on the upper extremity that would interfere with skin measurements of carotenoid levels such as active atopic dermatitis or psoriasis
  • Concurrent use of medications that affect the immune system, within 4 weeks of enrollment (eg. prednisone, biologics, methotrexate, rapamycin, prescription topical steroids, prescription inhaled steroids, others)
  • Unable to follow study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford Health - General Dermatology Clinic

Redwood City, California, 94063, United States

RECRUITING

Central Study Contacts

Xiaochen Zhong, BA

CONTACT

Po-Han Ho, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Dermatology

Study Record Dates

First Submitted

September 30, 2025

First Posted

October 28, 2025

Study Start

October 9, 2025

Primary Completion

March 1, 2026

Study Completion

April 1, 2026

Last Updated

December 15, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations